Literature DB >> 11925523

ECT for the treatment of psychiatric symptoms in Basedow's disease.

Masashi Nibuya1, Hisashi Sugiyama, Katsutoshi Shioda, Kenshi Nakamura, Koichi Nishijima.   

Abstract

To treat psychiatric symptoms associated with hyperthyroidism, we administered electroconvulsive therapy (ECT) to a patient with Basedow's disease. After unsuccessful treatment with an oral antithyroid drug, neuroleptics, and mood stabilizer, the patient recovered completely after three ECTs and did not relapse in the 40-day follow-up period. Although hyperthyroidism has been considered to induce psychiatric symptoms by enhancement of the sensitivity and turnover in catecholaminergic neurotransmission, we suggest another possible mechanism, involving translational and activational regulation of functional proteins in the brain.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11925523     DOI: 10.1097/00124509-200203000-00014

Source DB:  PubMed          Journal:  J ECT        ISSN: 1095-0680            Impact factor:   3.635


  4 in total

Review 1.  Psychiatric manifestations of Graves' hyperthyroidism: pathophysiology and treatment options.

Authors:  Robertas Bunevicius; Arthur J Prange
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

2.  Differences in the Treatment Response to Antithyroid Drugs versus Electroconvulsive Therapy in a Case of Recurrent Catatonia due to Graves' Disease.

Authors:  Takahiro Saito; Rie Saito; Hiroshi Suwa; Fumiatsu Yakushiji; Kenji Takezawa; Mitsuru Nakamura
Journal:  Case Rep Psychiatry       Date:  2012-06-12

Review 3.  How Electroconvulsive Therapy Works?: Understanding the Neurobiological Mechanisms.

Authors:  Amit Singh; Sujita Kumar Kar
Journal:  Clin Psychopharmacol Neurosci       Date:  2017-08-31       Impact factor: 2.582

4.  Seizure-Induced Arc mRNA Expression Thresholds in Rat Hippocampus and Perirhinal Cortex.

Authors:  Monica K Chawla; Daniel T Gray; Christie Nguyen; Harshaan Dhaliwal; Marc Zempare; Hiroyuki Okuno; Matthew J Huentelman; Carol A Barnes
Journal:  Front Syst Neurosci       Date:  2018-11-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.